AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 87 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $521,194 | -35.5% | 1,797,221 | 0.0% | 0.01% | -33.3% |
| Q4 2022 | $808,570 | -14.4% | 1,797,221 | 0.0% | 0.02% | -16.7% |
| Q3 2022 | $945,000 | +4.1% | 1,797,221 | 0.0% | 0.02% | +12.5% |
| Q2 2022 | $908,000 | -86.6% | 1,797,221 | -39.2% | 0.02% | -85.5% |
| Q1 2022 | $6,799,000 | -51.6% | 2,956,124 | 0.0% | 0.11% | -39.2% |
| Q4 2021 | $14,042,000 | -56.0% | 2,956,124 | -26.4% | 0.18% | -48.4% |
| Q3 2021 | $31,923,000 | +14.2% | 4,015,524 | 0.0% | 0.35% | +24.0% |
| Q2 2021 | $27,948,000 | -12.1% | 4,015,524 | 0.0% | 0.28% | -4.7% |
| Q1 2021 | $31,803,000 | +0.6% | 4,015,524 | 0.0% | 0.30% | +7.2% |
| Q4 2020 | $31,602,000 | +11.0% | 4,015,524 | 0.0% | 0.28% | -22.6% |
| Q3 2020 | $28,470,000 | -23.4% | 4,015,524 | 0.0% | 0.36% | -31.5% |
| Q2 2020 | $37,144,000 | +178.2% | 4,015,524 | +40.1% | 0.52% | +133.5% |
| Q1 2020 | $13,353,000 | -39.0% | 2,865,524 | 0.0% | 0.22% | -28.4% |
| Q4 2019 | $21,893,000 | -0.6% | 2,865,524 | 0.0% | 0.31% | -25.1% |
| Q3 2019 | $22,036,000 | +48.6% | 2,865,524 | +32.3% | 0.42% | +81.7% |
| Q2 2019 | $14,834,000 | -14.9% | 2,165,524 | 0.0% | 0.23% | -14.8% |
| Q1 2019 | $17,432,000 | +7.5% | 2,165,524 | 0.0% | 0.27% | -10.0% |
| Q4 2018 | $16,220,000 | -21.7% | 2,165,524 | 0.0% | 0.30% | +20.0% |
| Q3 2018 | $20,724,000 | +5.0% | 2,165,524 | +16.1% | 0.25% | +6.4% |
| Q2 2018 | $19,737,000 | +35.4% | 1,865,524 | +26.9% | 0.24% | +29.8% |
| Q1 2018 | $14,578,000 | +83.4% | 1,469,524 | 0.0% | 0.18% | +79.2% |
| Q4 2017 | $7,950,000 | +9.7% | 1,469,524 | 0.0% | 0.10% | +46.4% |
| Q3 2017 | $7,244,000 | +28.0% | 1,469,524 | 0.0% | 0.07% | +16.9% |
| Q2 2017 | $5,658,000 | -48.3% | 1,469,524 | 0.0% | 0.06% | -52.4% |
| Q1 2017 | $10,948,000 | +85.0% | 1,469,524 | +8.0% | 0.12% | +65.3% |
| Q4 2016 | $5,917,000 | -32.1% | 1,360,224 | 0.0% | 0.08% | -24.2% |
| Q3 2016 | $8,719,000 | +31.9% | 1,360,224 | 0.0% | 0.10% | +43.5% |
| Q2 2016 | $6,611,000 | – | 1,360,224 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 20,592 | $347,798 | 24.67% |
| VR Adviser, LLC | 295,034 | $3,614,167 | 0.38% |
| IFP Advisors, Inc | 2,860 | $1,718 | 0.00% |